SIMMUNOME AI
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy
SIMMUNOME AI
Industry:
Artificial Intelligence Biotechnology Genetics Health Care
Founded:
2016-01-01
Address:
Montreal, Quebec, Canada
Country:
Canada
Website Url:
http://www.simmunome.com
Total Employee:
1+
Status:
Active
Contact:
514-518-6292
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Nginx Sitelinks Search Box Euro
Similar Organizations
Current Employees Featured
Founder
Investors List
NEXT Canada
NEXT Canada investment in Pre Seed Round - Simmunome AI
Next AI
Next AI investment in Pre Seed Round - Simmunome AI
Official Site Inspections
http://www.simmunome.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Simmunome AI"
Simmunome AI - Crunchbase Company Profile & Funding
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases …See details»
Simmunome Inc. - LinkedIn
Simmunome Inc. | 993 followers on LinkedIn. Move your pipeline forward, with confidence. | We address the inefficiency of clinical trial success that is currently at >90% failure rate. …See details»
Simmunome Inc. | Canada Corporation Directory
Simmunome Inc. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 211-825 Boulevard Rene-Levesque Est Montreal QC H2L 0A1 Canada. It …See details»
Simmunome Inc. - The Org
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases …See details»
Simmunome Closes Pre-Seed Funding Round — Simmunome Inc.
Sep 18, 2023 MONTREAL, CANADA, April 11 — Montreal-based startup Simmunome has raised $2 million in pre-seed funding to increase the efficiency of clinical trials using artificial …See details»
Simmunome Company Profile 2024: Valuation, Funding
Simmunome General Information Description. Operator of a biotechnology company intended to address the inefficiency of clinical trial success. The company transforms physiological …See details»
Simmunome Company Profile | Management and Employees List
Simmunome's platform allows users to input preclinical and clinical data to derive disease-specific insights and help R&D researchers make critical go/no-go decisions. By combining multi-omic …See details»
Simmunome AI | Vitrine - IA
Simmunome is an artificial intelligence-based contract research organization. ... Mission. We develop industry-ready computational models of pathogenesis and immunogenesis of various …See details»
General 2 — Simmunome Inc.
At Simmunome, collaboration is at the heart of our mission to revolutionize therapeutic development through advanced simulation technologies. We proudly partner with leading …See details»
Simmunome Inc | Montreal, QC, Canada Startup - gust.com
Simmunome Inc Teaching Machines to Accurately Mimic Disease. Stage Prototype Ready Industry Biotechnology Location Montreal, QC, Canada Currency CAD Founded February …See details»
Simmunome AI - ACET
Simmunome is an AI driven company that focuses on untangling complex biological systems by combining innovative machine-learning methods and multi-omic biological data.See details»
Simmunome and Mila Announce Partnership to Advance AI in …
Nov 20, 2023 Simmunome de-risks clinical research, reduces R&D costs and dramatically accelerates health research and innovation. ... Mila is a globally recognized non-profit …See details»
The Neuro-CERVO Alliance Partners with Montreal-based AI …
Jul 18, 2023 Simmunome is at the leading edge of leveraging AI towards unraveling biological complexity. Simmunome’s clinical development platform allows users to input preclinical and …See details»
Simmunome - Overview, News & Similar companies | ZoomInfo.com
Aug 1, 2023 Simmunome de-risks clinical research, reduces R&D costs and dramatically accelerates health research and innovation. Read More. Simmunome's Social Media. Is this …See details»
Simmunome Revolutionising Drug Development — DISRUPTION …
Sep 25, 2024 Nardin envisions a future where Simmunome is integrated into the daily workflows of researchers and organizations, whether large pharmaceutical companies or smaller …See details»
Simmunome and Mila Announce Partnership to Advance AI in …
Nov 21, 2023 Simmunome integrates multi-omic data to generate in silico disease models that accurately capture physiological processes to avoid late-stage failures and increase efficacy in …See details»
SIMMUNOME -OUR SOLUTION USES AI TO ACCURATELY …
Simmunome is a Montreal-based startup established in 2018. We are focused on predicting clinical trial outcomes using computational simulations. ... With our approach, an R&D …See details»
Press - Simmunome Inc.
Simmunome’s expertise in simulating disease states will be an invaluable asset to shed light onto potential therapeutic targets for these devastating conditions. Read More. Tanya Tolomeo …See details»
Simmunome wins AI Award at 7th Annual Coopérathon Challenge
Dec 2, 2022 “Being recognized for our work in AI is not only honoured recognition, it validates the importance of the work we do for clinical research,” says Co-Founder and CTO Nardin …See details»